Genome Instability & Disease (GIAD)

Genome Instability & Disease (GIAD) publishes high-quality, peer-reviewed original research papers, short communications, reviews, research protocols and related articles on the molecular mechanisms underlying genome stability maintenance and genome instability-associated human diseases and therapeutic applications. In particular, GIAD publishes novel data regarding the regulatory mechanisms of genome stability, including epigenetic and post-translational modifications, and the DNA damage response and its association with the inheritance of mutations that contribute to genetic disorders, neurodegenerative diseases, cancer, and ageing.GIAD publishes one volume per year, consisting of six regular issues with a minimum of five original articles per issue. All submissions undergo a double-blind peer review process.

Genome Instability & Disease (GIAD) is :-

• International, Peer-Reviewed, Open Access, Refereed, Infectious Diseases, DNA damage and repair, cell cycle checkpoints, post‑translational modifications, epigenetic regulation, therapeutic sensitization strategies, genomic instability genes as therapeutic targets, Post-translational modifications, short communications, review articles, and research protocols from molecular biology, genetics, cell biology, medical research related to genome integrity , Online , Bi-Monthly Journal

• UGC Approved, ISSN Approved: P-ISSN E-ISSN: 2524-7662, Established: 2020,
• Does Not Provide Crossref DOI

• Not indexed in Scopus, WoS, DOAJ, PubMed, UGC CARE